CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 345 enrolled
Drug / intervention
Corellation of Mutations, TILs and Age in Breast Cancergenetic
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04033965
NCT04033965N/ACompleted
CompareCT.gov

Tumor Mutational Patterns and Infiltrating Lymphocyte Density in Young and Old Patients With Breast Cancer

Hellenic Cooperative Oncology Group·observational·Posted Jul 26, 2019·Updated Jul 26, 2019

In Brief

An observational study evaluating Corellation of Mutations, TILs and Age in Breast Cancer for Breast Cancer. Completed, enrolled 345 participants.

Detailed Summary

Age may pertain to different tumor genotype characteristics which may interfere with treatment efficacy and prognosis. The investigators investigated the distribution and prognostic effect of mutations (mut) and tumor infiltrating lymphocyte (TILs) in young and elderly early breast cancer patients (pts).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
Countries--
Collaborators--

Timeline

N/ACompletedFinished
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 26, 2019
Enrollment StartSep 3, 1997
Primary CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 13.1 yearsPosted 6.9 years ago

Interventions

Corellation of Mutations, TILs and Age in Breast Cancergenetic